Spotlight
Video

IV Daratumumab versus Subcutaneous Daratumumab

obr has 860 videos Subscribe Here

Loading........
Description: Saad Usmani, MD, Chief, Plasma Cell Disorders Program, Hematologic Malignancies, Levine Cancer Institute/Atrium Health, UNC Chapel Hill School of Medicine, compares intravenous daratumumab versus subcutaneous daratumumab.
Shared By : obr
Posted on : 07/02/19
Added : 2 months ago